nach oben

International Journal of Diabetes in Developing Countries

Erschienen in:

01.12.2015 | Original Article

Disturbed sleep in type 2 diabetes mellitus independent of chronic complications, pain, and nocturia

verfasst von: Rozita Nasseri, Mojtaba Malek, Rokhsareh Aghili, Ameneh Ebrahim Valojerdi, Mohammad Ebrahim Khamseh

Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

This study was to compare the sleep quality in people with type 2 diabetes with healthy controls and to investigate the association of diabetes and sleep quality in people with type 2 diabetes without chronic complications. We also explored the effect of pain, nocturia, and obstructive sleep apnea (OSA) on sleep quality. Four hundred and five people were recruited in this case-control study. Sleep quality was assessed in 202 people with type 2 diabetes and was compared with 203 healthy individuals. All diabetic people were free from chronic complications. The Persian version of Pittsburgh Sleep Quality Index (PSQI) was used for the assessment of sleep quality. Poor sleep quality was defined as PSQI score >5. Poor sleep quality was more prevalent in people with type 2 diabetes. The odds ratio for poor sleep quality was 2.63 in people with long-standing diabetes (diabetes duration ≥10 years). Although the PSQI score was slightly better in diabetic people without pain/nocturia (P = 0.03), the prevalence of disturbed sleep showed no significant change after excluding these people from analysis. Diabetes was associated with 1.77-fold increase in risk of OSA, and poor sleep quality was more frequent in diabetic people at high risk for OSA (P = 0.005) independent of body weight. Long-standing diabetes was a significant predictor of poor sleep quality. Furthermore, the effect of diabetes on sleep quality was independent of its complications and other intervening risk factors such as pain/nocturia. Diabetes was also associated with OSA, stronger than the observed association between obesity and OSA.

Martins RC, Andersen ML, Tufik S. The reciprocal interaction between sleep and type 2 diabetes mellitus: facts and perspectives. Braz J Med Biol Res. 2008;41(3):180–7.CrossRefPubMed

Kripke DF, Simons RN, Garfinkel L, Hammond EC. Short and long sleep and sleeping pills. Is increased mortality associated? Arch Gen Psychiatry. 1979;36(1):103–16.CrossRefPubMed

Terzano MG, Parrino L, Cirignotta F, Ferini-Strambi L, Gigli G, Rudelli G, et al. Studio Morfeo: insomnia in primary care, a survey conducted on the Italian population. Sleep Med. 2004;5(1):67–75.CrossRefPubMed

Walsh J, Benca R, Bonnet M, Buysse D, Hauri P, Kiley J, et al. Insomnia: assessment and management in primary care. Am Fam Physician. 1999;59(11):3029–38.

Aikens JE, Rouse ME. Help-seeking for insomnia among adult patients in primary care. J Am Board Fam Pract. 2005;18(4):257–61.CrossRefPubMed

Shochat T, Umphress J, Israel AG, Ancoli-Israel S. Insomnia in primary care patients. Sleep. 1999;22 Suppl 2:S359–65.PubMed

Gangwisch JE, Malaspina D, Boden-Albala B, Heymsfield SB. Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. Sleep. 2005;28(10):1289–96.PubMed

Hasler G, Buysse DJ, Klaghofer R, Gamma A, Ajdacic V, Eich D, et al. The association between short sleep duration and obesity in young adults: a 13-year prospective study. Sleep. 2004;27(4):661–6.PubMed

Knutson KL, Spiegel K, Penev P, Van Cauter E. The metabolic consequences of sleep deprivation. Sleep Med Rev. 2007;11(3):163–78. doi:10.1016/j.smrv.2007.01.002.PubMedCentralCrossRefPubMed

10.

Lou P, Chen P, Zhang L, Zhang P, Yu J, Zhang N, et al. Relation of sleep quality and sleep duration to type 2 diabetes: a population-based cross-sectional survey. BMJ open. 2012;2(4):e000956.

11.

Brooks B, Cistulli PA, Borkman M, Ross G, McGhee S, Grunstein RR, et al. Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab. 1994;79(6):1681–5.PubMed

12.

Gottlieb DJ, Punjabi NM, Newman AB, Resnick HE, Redline S, Baldwin CM, et al. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med. 2005;165(8):863–7. doi:10.1001/archinte.165.8.863.CrossRefPubMed

13.

Kita T, Yoshioka E, Satoh H, Saijo Y, Kawaharada M, Okada E, et al. Short sleep duration and poor sleep quality increase the risk of diabetes in Japanese workers with no family history of diabetes. Diabetes Care. 2012;35(2):313–8. doi:10.2337/dc11-1455.PubMedCentralCrossRefPubMed

14.

Hayashino Y, Fukuhara S, Suzukamo Y, Okamura T, Tanaka T, Ueshima H. Relation between sleep quality and quantity, quality of life, and risk of developing diabetes in healthy workers in Japan: the High-risk and Population Strategy for Occupational Health Promotion (HIPOP-OHP) Study. BMC Public Health. 2007;7:129. doi:10.1186/1471-2458-7-129.PubMedCentralCrossRefPubMed

15.

Spiegel K, Knutson K, Leproult R, Tasali E, Van Cauter E. Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. J Appl Physiol. 2005;99(5):2008–19. doi:10.1152/japplphysiol.00660.2005.CrossRefPubMed

16.

Van Cauter E, Polonsky KS, Scheen AJ. Roles of circadian rhythmicity and sleep in human glucose regulation. Endocr Rev. 1997;18(5):716–38.PubMed

17.

Resnick HE, Redline S, Shahar E, Gilpin A, Newman A, Walter R, et al. Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. Diabetes Care. 2003;26(3):702–9.CrossRefPubMed

18.

Sridhar GR, Madhu K. Prevalence of sleep disturbances in diabetes mellitus. Diabetes Res Clin Pract. 1994;23(3):183–6.CrossRefPubMed

19.

Scheen AJ, Byrne MM, Plat L, Leproult R, Van Cauter E. Relationships between sleep quality and glucose regulation in normal humans. Am J Physiol. 1996;271(2 Pt 1):E261–70.PubMed

20.

Ayas NT, White DP, Al-Delaimy WK, Manson JE, Stampfer MJ, Speizer FE, et al. A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care. 2003;26(2):380–4.CrossRefPubMed

21.

Gislason T, Almqvist M. Somatic diseases and sleep complaints. An epidemiological study of 3,201 Swedish men. Acta Med Scand. 1987;221(5):475–81.CrossRefPubMed

22.

Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem. 2004;50(9):1511–25. doi:10.1373/clinchem.2004.032482.CrossRefPubMed

23.

Tasali E, Mokhlesi B, Van Cauter E. Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest. 2008;133(2):496–506. doi:10.1378/chest.07-0828.CrossRefPubMed

24.

Tasali E, Ip MS. Obstructive sleep apnea and metabolic syndrome: alterations in glucose metabolism and inflammation. Proc Am Thorac Soc. 2008;5(2):207–17. doi:10.1513/pats.200708-139MG.CrossRefPubMed

25.

West SD, Nicoll DJ, Stradling JR. Prevalence of obstructive sleep apnoea in men with type 2 diabetes. Thorax. 2006;61(11):945–50. doi:10.1136/thx.2005.057745.PubMedCentralCrossRefPubMed

26.

Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med. 2002;165(5):670–6. doi:10.1164/ajrccm.165.5.2103001.CrossRefPubMed

27.

Farrahi Moghaddam J, Nakhaee N, Sheibani V, Garrusi B, Amirkafi A. Reliability and validity of the Persian version of the Pittsburgh Sleep Quality Index (PSQI-P). Sleep Breath. 2012;16(1):79–82. doi:10.1007/s11325-010-0478-5.CrossRefPubMed

28.

Sleep Medicine Institute. Pittsburgh Sleep Quality Index (PSQI). http://www.sleep.pitt.edu/content.asp?id=1484&subid=2316. Accessed 23 Apr 2013.

29.

Qaseem A, Dallas P, Owens DK, Starkey M, Holty JE, Shekelle P. Diagnosis of obstructive sleep apnea in adults: a clinical practice guideline from theAmerican College of Physicians. Ann Intern Med. 2014;161(3):210–20. doi:10.7326/m12-3187.CrossRefPubMed

30.

Nakajima H, Kaneita Y, Yokoyama E, Harano S, Tamaki T, Ibuka E, et al. Association between sleep duration and hemoglobin A1c level. Sleep Med. 2008;9(7):745–52. doi:10.1016/j.sleep.2007.07.017.CrossRefPubMed

31.

Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354(9188):1435–9. doi:10.1016/s0140-6736(99)01376-8.CrossRefPubMed

32.

Kawakami N, Takatsuka N, Shimizu H. Sleep disturbance and onset of type 2 diabetes. Diabetes Care. 2004;27(1):282–3.CrossRefPubMed

33.

Nilsson PM, Roost M, Engstrom G, Hedblad B, Berglund G. Incidence of diabetes in middle-aged men is related to sleep disturbances. Diabetes Care. 2004;27(10):2464–9.CrossRefPubMed

34.

Yaggi HK, Araujo AB, McKinlay JB. Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care. 2006;29(3):657–61.CrossRefPubMed

35.

Song Y, Ye X, Ye L, Li B, Wang L, Hua Y. Disturbed subjective sleep in Chinese females with type 2 diabetes on insulin therapy. PLoS One. 2013;8(1):e54951. doi:10.1371/journal.pone.0054951.PubMedCentralCrossRefPubMed

36.

Tsai YW, Kann NH, Tung TH, Chao YJ, Lin CJ, Chang KC, et al. Impact of subjective sleep quality on glycemic control in type 2 diabetes mellitus. Fam Pract. 2012;29(1):30–5. doi:10.1093/fampra/cmr041.CrossRefPubMed

37.

Knutson KL, Ryden AM, Mander BA, Van Cauter E. Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus. Arch Intern Med. 2006;166(16):1768–74. doi:10.1001/archinte.166.16.1768.CrossRefPubMed

38.

Lamond N, Tiggemann M, Dawson D. Factors predicting sleep disruption in Type II diabetes. Sleep. 2000;23(3):415–6.PubMed

39.

Vgontzas AN, Tan TL, Bixler EO, Martin LF, Shubert D, Kales A. Sleep apnea and sleep disruption in obese patients. Arch Intern Med. 1994;154(15):1705–11.CrossRefPubMed

40.

Trento M, Broglio F, Riganti F, Basile M, Borgo E, Kucich C, et al. Sleep abnormalities in type 2 diabetes may be associated with glycemic control. Acta Diabetol. 2008;45(4):225–9. doi:10.1007/s00592-008-0047-6.CrossRefPubMed

Titel: Disturbed sleep in type 2 diabetes mellitus independent of chronic complications, pain, and nocturia
verfasst von: Rozita Nasseri
Mojtaba Malek
Rokhsareh Aghili
Ameneh Ebrahim Valojerdi
Mohammad Ebrahim Khamseh
Publikationsdatum: 01.12.2015
Verlag: Springer India
Erschienen in: International Journal of Diabetes in Developing Countries / Ausgabe 4/2015
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI: https://doi.org/10.1007/s13410-015-0314-3

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2015

Risk factors for proteinuria and renal insufficiency in Asian Indian patients with type 2 diabetes

Death due to hypoglycemia: medico-legal implications

Role of prolactin as a cardiovascular risk in type 2 diabetes mellitus patients: a case-control study in Egypt

Etiologic diagnosis of diabetes mellitus in adults: questions to ask, tests to request

Socio-demographic and lifestyle factors associated with dietary patterns among adults with type 2 diabetes mellitus in Tehran, Iran

Utility of MDRF-IDRS (Madras Diabetes Research Foundation-Indian Diabetes Risk Score) as a tool to assess risk for diabetes—a study from north-west India